A century of pneumococcal vaccination research in humans ,
, Clin Microbiol Infect, vol.18, issue.5, pp.15-24, 2012.
A brief history of pneumococcal vaccines, Drugs Aging, vol.15, pp.1-10, 1999. ,
Changing interest among physicians toward pneumococcal vaccination throughout the twentieth century, J Hist Med Allied Sci, vol.59, issue.4, pp.555-87, 2004. ,
, Lancet, vol.374, pp.1543-56, 2009.
Streptococcus pneumoniae: epidemiology, risk factors, and strategies forprevention. Seminars in respiratory and critical care medecine, vol.30, pp.189-209, 2009. ,
Streptococcus pneumoniae meningitis morbidity and mortality: results from the French national meningitis cohort(COMBAT) 2016 ,
, Haut Conseil de la santé publique, Avis relatif aux recommandations vaccinales contre les infections à pneumocoque pour les adultes 10 mars, 2017.
, Incidence redressée pour défaut de couverture et corrigée pour sous notifications, 2014.
, Epibac 2014 et étude, surveillance des infections invasives à pneumocoques chez l'adulte, SIIPA 2012-2015, données ORP-CNRP-Spilf-ANSP non publiées, estimation ANSP
, Immunological Memory, vol.46, pp.1015-1023, 2008.
Immunogenicity and safety of a 13 valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naïve adults, Vaccine, vol.31, pp.3577-84, 2011. ,
A randomized study comparing combined pneumococcal conjugate and polysaccharide vaccination in adults, Clin Infect Dis, vol.52, pp.736-778, 2011. ,
Immunogenicity and safety of a 13 valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine, Vaccine, vol.31, pp.3585-93, 2013. ,
The impact of age on the efficacy of 13-valent pneumococcal conjugate vaccine in elderly, Clin Infect Dis, vol.61, pp.1835-1843, 2015. ,
Post hoc assessment of duration of protection in CAPITA, Trials in Vaccinology, vol.5, pp.92-98, 2016. ,
Vaccines for preventing pneumococcal infection in adults (review).The Cochrane Collaboration. The Cochrane Library, p.422, 2008. ,
Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev, p.422, 2013. ,
Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease. Cochrane Database Syst Rev, vol.001390, 2017. ,
Effectiveness of the 23-valent pneumococcal polysaccharide vaccine (PP23) against pneumococcal disease in the elderly : systematic review and meta-analysis, PLoS ONE 2017, vol.12, issue.1, p.169368 ,
Impact and effectiveness of 23-valent pneumococcal vaccines against invasive pneumococcal disease in the elderly in England and Wales, Vaccine, vol.30, pp.6802-6810, 2012. ,
Serotype specific effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia in adults aged 65 years or older : a multicentre, prospective, test-negative design study, Lancet Infect Dis, vol.17, issue.3, pp.313-321, 2017. ,
Sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naïve adults 60-64 years of age, Vaccine, vol.32, pp.2364-74, 2014. ,
, Méthode générale de la cartographie des pathologies, version G5 (années, 2012.
, Mise à jour : 8 mars, Caisse Nationale d'Assurance Maladie (CNAM), 2018.
, des Etudes et des Statistiques -Département des Etudes sur les Pathologies et les Patients
,
, Influenza and pneumococcal vaccine coverage among patients admitted to an acute geriatric unit, vol.11, pp.7-14
, Gerontology, vol.53, issue.6, pp.382-389, 2007.
, Influenza and pneumococcal vaccine coverages in geriatric health care settings in france, Epub, 2007.
, Med Mal Infect, vol.40, issue.6, pp.341-347, 2010.
, Ann Pharm Fr, 2016.
, Antipneumococcal vaccine coverage for hospitalized risk patients: Assessment and suggestions for improvements, vol.74, pp.244-51, 2015.
Influenzae and pneumococcal vaccination rate in an internal medicine ward, Rev Med Interne, vol.39, issue.6, pp.386-392, 2018. ,
Vaccination coverage against influenza and pneumococcus for patients admitted to a pulmonary care service, vol.30, pp.746-51, 2013. ,
,
, Med Mal Infect, vol.43, issue.1, pp.22-29, 2013.
, Streptococcus pneumoniae vaccinal coverage in hospitalized elderly patients in
L'intergroupe Société de pathologie infectieuse de langue française/Société de gériatrie et gérontologie clinique (SPILF/SGGC) ,
, Pneumococcal vaccination coverage among persons ?65 years--United States, vol.33, pp.5503-5506, 2013.
, Hum Vaccin Immunother, vol.12, issue.11, pp.2953-2958, 2016.
, Pneumococcal vaccination coverages among low-, intermediate-, and high-risk adults in Catalonia, Epub, 2016.
, La Vaccination antipnumococcique chez l'adulte en région PACA-Corse: étude des prescriptions et du suivi des recommandations. p23-26 Dr Jonathan Lyon-Bilger, sous la direction du Dr Sébastien Adnot, 2013.
, , p.6, 2016.
, La Vaccination antipneumococcique chez l'adulte en région PACA-Corse: étude des prescriptions et du suivi des recommandations. p33-36 Dr Jonathan Lyon-Bilger, sous la direction du Dr Sébastien Adnot, 2013.
, Direction Générale de la Santé (Ministère des Affaires sociales, de la Santé et de la Solidarité), Calendrier des vaccinations et recommandations vaccinales 2017, pp.23-24